Rising Health Costs and Margin Pressure Impacting UNH
- Unexpected surge in health costs impacted UNH's Q4 2025 performance and 2026 outlook
- Led to lowered revenue guidance and margin compression, especially in Medicare Advantage
- Stock declined -1.94% on March 3 (settling at $289.21) and is down -3.3% since last earnings
- Underperformance relative to the S&P 500 due to cost pressures
- Near-term downside risk with support level around $285 and resistance at ~$295